177 related articles for article (PubMed ID: 1839955)
1. Photodynamic therapy of murine skin tumors using Photofrin-II.
Mukhtar H; Agarwal R; Athar M; Lewen RL; Elmets CA; Bickers DR
Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):169-75. PubMed ID: 1839955
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of chemically- and ultraviolet B radiation-induced murine skin papillomas by chloroaluminum phthalocyanine tetrasulfonate.
Agarwal R; Athar M; Elmets CA; Bickers DR; Mukhtar H
Photochem Photobiol; 1992 Jul; 56(1):43-50. PubMed ID: 1508981
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
6. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
[TBL] [Abstract][Full Text] [Related]
7. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
9. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
10. Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine: a novel candidate in photodynamic therapy for skin cancer models in vivo.
Gayathri Devi D; Cibin TR; Ramaiah D; Abraham A
J Photochem Photobiol B; 2008 Sep; 92(3):153-9. PubMed ID: 18653354
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro.
Boehncke WH; Rück A; Naumann J; Sterry W; Kaufmann R
Lasers Surg Med; 1996; 19(4):451-7. PubMed ID: 8983006
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy.
Ahmad N; Kalka K; Mukhtar H
Oncogene; 2001 Apr; 20(18):2314-7. PubMed ID: 11402326
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
14. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075
[TBL] [Abstract][Full Text] [Related]
16. [Photosensitizer nanoparticles photodynamic therapy on LOVO human colon cancer xenografts in athymic mice].
Qing SH; Li LY; Sheng XH; Ba MC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):530-3. PubMed ID: 17143803
[TBL] [Abstract][Full Text] [Related]
17. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy.
Ferrario A; Gomer CJ
Cancer Res; 1990 Feb; 50(3):539-43. PubMed ID: 2137023
[TBL] [Abstract][Full Text] [Related]
18. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse.
Starkey JR; Rebane AK; Drobizhev MA; Meng F; Gong A; Elliott A; McInnerney K; Spangler CW
Clin Cancer Res; 2008 Oct; 14(20):6564-73. PubMed ID: 18927297
[TBL] [Abstract][Full Text] [Related]
19. Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy.
Menon C; Kutney SN; Lehr SC; Hendren SK; Busch TM; Hahn SM; Fraker DL
Clin Cancer Res; 2001 Dec; 7(12):3904-11. PubMed ID: 11751481
[TBL] [Abstract][Full Text] [Related]
20. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
